RAPT Therapeutics (RAPT) Change in Acquisitions & Divestments (2020 - 2024)
Historic Change in Acquisitions & Divestments for Therapeutics (RAPT) over the last 5 years, with Q4 2024 value amounting to $30.0 million.
- Therapeutics' Change in Acquisitions & Divestments fell 6056.08% to $30.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $135.0 million, marking a year-over-year decrease of 4937.6%. This contributed to the annual value of $135.0 million for FY2024, which is 4937.6% down from last year.
- Per Therapeutics' latest filing, its Change in Acquisitions & Divestments stood at $30.0 million for Q4 2024, which was down 6056.08% from $35.9 million recorded in Q3 2024.
- Over the past 5 years, Therapeutics' Change in Acquisitions & Divestments peaked at $76.0 million during Q4 2023, and registered a low of $1.4 million during Q4 2021.
- For the 5-year period, Therapeutics' Change in Acquisitions & Divestments averaged around $36.0 million, with its median value being $32.8 million (2024).
- Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first crashed by 9557.54% in 2021, then skyrocketed by 248341.5% in 2022.
- Therapeutics' Change in Acquisitions & Divestments (Quarter) stood at $32.3 million in 2020, then crashed by 95.58% to $1.4 million in 2021, then soared by 2483.41% to $36.9 million in 2022, then skyrocketed by 105.77% to $76.0 million in 2023, then crashed by 60.56% to $30.0 million in 2024.
- Its Change in Acquisitions & Divestments stands at $30.0 million for Q4 2024, versus $35.9 million for Q3 2024 and $36.4 million for Q2 2024.